Kenacort-A 40, suspensie voor injectie 40 mg/ml, Jyseleca 200 mg film-coated tablets clinical trials

Filgotinib bridging in newly diagnosed rheumatoid arthritis patients (FAST RA trial); A pragmatic randomized controlled non-inferiority low intervention clinical trial

This study is testing different treatments for new rheumatoid arthritis to see which works best at getting people into remission quickly. It compares a steroid injection (Kenacort-A) with a newer tablet (Jyseleca) to find out how many people feel much better after three months.